» Articles » PMID: 12759894

Total Energy Expenditure and Carbohydrate Oxidation Are Increased in the Human Immunodeficiency Virus Lipodystrophy Syndrome

Overview
Journal Metabolism
Specialty Endocrinology
Date 2003 May 22
PMID 12759894
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

To determine whether total energy expenditure (TEE) is increased in the human immunodeficiency virus (HIV) lipodystrophy syndrome, we compared energy expenditure (EE) and substrate oxidation rates in 12 HIV-infected men with lipodystrophy, 7 HIV-infected men without lipodystrophy, and 14 healthy controls. TEE and nutrient oxidation rates were assessed by whole-room indirect calorimetry. Resting energy expenditure (REE) was measured by indirect calorimetry using the open-circuit technique. Body composition was assessed by dual-energy x-ray absorptiometry (DEXA). Insulin sensitivity was measured using the insulin-modified frequently sampled intravenous glucose tolerance test. TEE adjusted for lean body mass (LBM) was significantly higher in the HIV-infected group with lipodystrophy compared to HIV-infected patients without lipodystrophy (2,873.3 +/- 69 v 2,573.9 +/- 92 kcal/d, P =.02) and compared to healthy controls (2,873.3 +/- 69 v 2,404.0 +/- 64 kcal/d, P <.001). REE and sleeping metabolic rate (SMR) adjusted for LBM were also significantly higher in the HIV-infected group with lipodystrophy compared to both HIV-infected and healthy controls. Carbohydrate oxidation rates adjusted for LBM were higher in men with HIV lipodystrophy as compared to healthy controls (362.5 +/- 23 v 250.0 +/- 22 g/d, P = <.01) and tended to be higher as compared to HIV-infected controls (362.5 +/- 23.6 v 297.3 +/- 31 g/d, P =.1). In conclusion, TEE and carbohydrate oxidation are increased in the HIV lipodystrophy syndrome. The increase in TEE appears to be due to increases in REE. The pathogenesis of elevated EE in HIV lipodystrophy and other forms of lipodystrophy remains to be determined.

Citing Articles

Patients living with HIV have quantitatively inadequate food consumption.

Vercesi B, Moscardini I, Esteves G, Beraldo R Arch Endocrinol Metab. 2023; 67(5):e000623.

PMID: 37249454 PMC: 10665049. DOI: 10.20945/2359-3997000000623.


Immunometabolic Reprogramming in Response to HIV Infection Is Not Fully Normalized by Suppressive Antiretroviral Therapy.

Deme P, Rubin L, Yu D, Xu Y, Nakigozi G, Nakasujja N Viruses. 2022; 14(6).

PMID: 35746785 PMC: 9228482. DOI: 10.3390/v14061313.


Physical activity and capacity at initiation of antiretroviral treatment in HIV patients in Ethiopia.

Olsen M, Kaestel P, Tesfaye M, Abdissa A, Yilma D, Girma T Epidemiol Infect. 2014; 143(5):1048-58.

PMID: 25034136 PMC: 9507108. DOI: 10.1017/S0950268814001502.


Energy expenditure in HIV infection.

Kosmiski L Am J Clin Nutr. 2011; 94(6):1677S-1682S.

PMID: 22089443 PMC: 3226020. DOI: 10.3945/ajcn.111.012625.


Dual-energy X-ray absorptiometry modeling to explain the increased resting energy expenditure associated with the HIV lipoatrophy syndrome.

Kosmiski L, Ringham B, Grunwald G, Bessesen D Am J Clin Nutr. 2009; 90(6):1525-31.

PMID: 19828707 PMC: 2777466. DOI: 10.3945/ajcn.2009.28103.